Navigation Links
Cephalon Wins FENTORA Patent Suit Against Watson
Date:3/24/2011

FRAZER, Pa., March 24, 2011 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) announced that today the United States District Court in Delaware upheld the validity of Cephalon's U.S. Patent Number 6,264,981 patent and found that Watson Pharmaceuticals, Inc.'s proposed generic version of FENTORA® (fentanyl buccal tablet) infringes that patent.  The Court also denied Watson's motion to vacate a previously entered injunction preventing Watson from marketing its product.

"We are pleased with the court's ruling upholding the validity of our patent, as well as its finding that Watson's product infringes that patent," said Jerry Pappert, Executive Vice President and General Counsel of Cephalon.  

This decision pertained to patent litigation brought by Cephalon and its wholly-owned subsidiary CIMA Labs, Inc., against Watson Pharmaceuticals, Inc., and its wholly-owned subsidiary Watson Laboratories, Inc., regarding Cephalon's FENTORA product.  

FENTORA was approved by the U.S. Food and Drug Administration (FDA) in September 2006.

About Cephalon, Inc.

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cepha
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Definitive Agreement to Acquire Gemin X
2. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
3. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
4. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
5. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
6. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
7. Cephalon to Webcast Investor Day
8. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
9. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
10. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
11. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
(Date:3/26/2015)... , March 26, 2015  Desert Valley Medical Center, ... times , is the first U.S. hospital to ... emergency department to help clinicians prevent hospital acquired pressure ... Victorville, Calif. , is a community hospital serving ... Using the Leaf Patient Monitor in the hospital,s emergency ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... within 5,minutes of dosing and is well-tolerated , ... Ltd,("Archimedes"), a European specialty pharmaceutical company, today,presented new ... Nasalfent(r),an innovative fentanyl citrate nasal spray aimed at ... cancer,pain. Data were presented at the 10th Congress ...
... dosed every two weeks achieved an SVR rate ... analysis), with,more favorable quality-of-life scores -, ROCKVILLE, Md., ... today announced the top-line final results of,a Phase ... with ribavirin in treatment-naive patients with,genotype 1 chronic ...
Cached Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 The American ... will be on the topics of the DAOM Program as ... DAOM Program Overview Webinar will be hosted by Dr. Carla ... provide the next steps on how to prepare for the ... p.m. March 25, March 27, April 1 and April 3. ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... PA (PRWEB) March 26, 2015 The ... a new team of nationally renowned scientists to focus ... B, a move that nearly triples its research capacity ... focusing solely on hepatitis B and liver cancer in ... Timothy Block, Jinhong Chang, Ju Tao Guo and Ying-Hsiu ...
(Date:3/26/2015)... 2015 Behavioral Research Group, LLC ... the release of BathroomMap® , a new bathroom ... to public restrooms for travelers, especially those with medical ... does not facilitate a paid, social or crowdsourced model, ... rate local establishments that have clean, available restrooms in ...
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... Lighting the Way, Brightening the Day, on Friday, May ... in Morristown, NJ. , Guests will enjoy an ... Clemente, delightful cuisine, an extensive silent auction and heart-warming ... prestigious awards will be presented to this year’s honorees. ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI) ... the nutraceutical industry engaged in the,development, manufacture ... and personal care products in the People,s ... has retained CCG Elite to design,and execute ...
... About the Importance of Regular Eye Care, ... the nationwide launch of its "See America" contest, ... preventive eye exams to promote,overall vision health. The ... sight will award the grand prize winner,with the ...
... Clinicogenomic Model Has Highest Prediction Accuracy for Lung ... an emerging,leader in the field of molecular diagnostics ... model for lung cancer diagnosis in the,inaugural edition ... American Association for Cancer Research (AACR), which is ...
... to expand the $200 million surgical ... Group, WALTHAM, Mass., April 14, 2008 According ... 2008 report,the surgical navigation market was worth almost $200 ... five years. This growth will be partly,facilitated by soft ...
... BioElectronics President, CEO, and Chairman Issues Shareholder ... Andrew Whelan,President, CEO and Chairman of BioElectronics, ... FDA-cleared, drug-free anti-inflammatory patch,with an embedded battery ... relieve pain and speed healing, today issued ...
... 14 The rating,agency Standard & Poor,s has raised ... stable". This means that Gerresheimer is now only one,step ... justification for the upgrade, Standard & Poor,s emphasises the,positive ... EBITDA.,Gerresheimer, it says, will be able to sustain this ...
Cached Medicine News:Health News:China Yingxia International, Inc. Retains CCG Elite 2Health News:China Yingxia International, Inc. Retains CCG Elite 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 2Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 4Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 2Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 3Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 2Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 2Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 4Health News:Standard & Poor's Raises Gerresheimer Rating to BB+ 2
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... immunoassay system is a ... analyzer that performs a ... panels that include anemia, ... disease, blood virus, skeletal, ...
...
Medicine Products: